Tangible Shareholders Equity: The value shareholders equity less intangible assets.
XORTX Therapeutics Inc. (XRTX) had Tangible Shareholders Equity of $1.78M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.65M |
|
-- |
|
-- |
|
$0.72M |
|
$-0.72M |
|
$0.07M |
|
$-0.65M |
|
$-0.65M |
|
$-0.65M |
|
$-0.65M |
|
$-0.65M |
|
$-0.65M |
|
$-0.72M |
|
$-0.69M |
|
4.86M |
|
4.86M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$1.36M |
|
$0.06M |
|
$1.45M |
|
$2.81M |
|
$0.84M |
|
-- |
|
-- |
|
$0.84M |
|
$1.97M |
|
|
Tangible Shareholders Equity |
$1.78M |
$1.97M |
|
5.21M |
|
| Cash Flow Statement Financials | |
$-2.07M |
|
$-0.03M |
|
$0.80M |
|
$2.47M |
|
$1.19M |
|
$-1.28M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.62 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.91% |
|
-36.49% |
|
-23.10% |
|
-32.91% |
|
$0.38 |
|
$-0.43 |
|
$-0.43 |
|